由FGFR驱动的肺癌:剖析抵抗和探索治疗途径
Pengfei Zhang1, Wuxuan Mei2, Yueru Yao3
1Department of Medical Laboratory, Shenzhen Longhua District Central Hospital, Shenzhen, 518110, China.
Critical reviews in oncology/hematology
|February 12, 2026
概括
纤维细胞生长因子受体 (FGFR) 抑制剂在肺癌中表现有前途,但耐药性限制了它们的有效性. 本综述探讨了FGFR生物学,耐药性机制以及克服精密瘤学治疗挑战的策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 纤维细胞生长因子受体 (FGFRs) 是肺癌发展的关键驱动因素.
- 向FGFRs代表了肺癌治疗精确瘤学的重大进步.
研究的目的:
- 审查FGFR生物学,基因组改变和肺癌中的信号.
- 讨论当前的FGFR抑制剂及其临床活性.
- 总结抵抗机制和克服它们的新策略.
主要方法:
- 关于FGFR生物学,瘤发生和治疗策略的文献评论.
- 对抗性机制的分析,包括二次突变和途径改变.
- 探索新兴的治疗方法和组合策略.
主要成果:
- 在肺癌中,FGFR的改变很常见,抑制剂显示临床活性.
- 不同的抵抗机制,包括二次突变和TME重塑,限制了疗效.
- 第二代抑制剂,mAbs,FGF陷,ADC和组合疗法是新兴的策略.
结论:
- 了解FGFR生物学和耐药性对于有效的肺癌治疗至关重要.
- 需要新的治疗策略来克服对FGFR导向疗法的抗性.
- 组合方法有望提高FGFR改变的肺癌治疗结果.
更多相关视频
11:31Using Micro-computed Tomography for the Assessment of Tumor Development and Follow-up of Response to Treatment in a Mouse Model of Lung Cancer
Published on: May 20, 2016
11.3K
07:46In vivo Imaging and Therapeutic Treatments in an Orthotopic Mouse Model of Ovarian Cancer
Published on: August 17, 2010
34.6K
相关概念视频
Treatment Resistant Cancers
3.8K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K
Lung Capacity
56.4K
The air in the lungs is measured in volumes and capacities. Lung volume measures reflect the amount of air taken in, released, or left over after a lung function, like a single inhalation. Lung capacity measures are sums of two or more lung volume measures.
56.4K
Resistivity
4.6K
When a voltage is applied to a conductor, an electrical field is generated, and charges in the conductor feel the force due to the electrical field. The current density that results depends on the electrical field and the properties of the material. In some materials, including metals at a given temperature, the current density is approximately proportional to the electrical field. In these cases, the current density can be modeled as:
4.6K
Resistance
6.1K
When a current moves through any conductor, the conductor causes some level of difficulty for the current to flow. The measure of that difficulty is known as the resistance of the material and is represented by R. Every material has its own resistance. In the case of conductors, heat is emitted whenever a current passes through them. Resistance depends on the resistivity of the material. Resistivity is a characteristic of the material used to fabricate electrical components, whereas the...
6.1K
Therapeutic Index
6.9K
The therapeutic index of a drug is a key parameter in pharmacology that quantifies the relative safety of a drug by calculating the ratio between the dose that causes toxicity in half the population (50%) to the dose that proves to be effective for half the population (50%). It provides a spectrum of doses for a particular drug ranging from effective to potentially toxic. To illustrate, consider an anticoagulant agent like warfarin. It possesses a narrow window within its therapeutic index to...
6.9K
ATP Driven Pumps I: An Overview
10.0K
ATP-driven pumps, also known as transport ATPases, are integral membrane proteins. They have binding sites for ATP located on the membrane's cytosolic side and the ion-conducting domain in the transmembrane region. These pumps use the free energy released from ATP hydrolysis to move the solutes across cell membranes against an electrochemical gradient.
There are four main types of ATP-driven pumps - P-type, V-type, F-type, and ABC transporter. All these pumps are of varying complexities and...
There are four main types of ATP-driven pumps - P-type, V-type, F-type, and ABC transporter. All these pumps are of varying complexities and...
10.0K
